Lobaplatin-Based Regimen May Be ‘Promising’ Alternative for Nasopharyngeal Carcinoma
Treatment-related toxicities were less likely with the lobaplatin-based regimen.
Head and Neck Cancer News
HEAD AND NECK CANCER ADVISOR
Head and Neck Cancer News
Two Doses of COVID-19 Vaccine Appear Necessary to Protect Cancer Patients on Active Treatment
Cancer patients had a low rate of seropositivity after the first vaccine dose but not after the second dose.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Closing the Gap Between Cancer Patients and Researchers: A Patient Advocate’s Perspective on GRASP
Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Epigenetic Clock May Reveal Biological Aging After Cancer Treatment and Allow for Objective Measurement of Fatigue
Researchers found associations between epigenetic age acceleration, inflammation, and fatigue in cancer patients.
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
African-American Patients Have Worse Outcomes of Oropharyngeal Cancer Regardless of Access to Medical Care
Findings suggest a need for tailored treatment in oropharyngeal squamous cell carcinoma.
Camrelizumab Plus Chemo Could Be New Standard for Recurrent, Metastatic Nasopharyngeal Carcinoma
The combination significantly prolonged progression-free survival.
Toripalimab May ‘Offer New Hope’ For Patients With Advanced Nasopharyngeal Carcinoma
Adding toripalimab to chemotherapy improved progression-free survival.
Age and Race May Determine Whether Cancer Patients Access Their Electronic Health Records
Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records.
Adding Avelumab to Standard Care Doesn’t Improve PFS in Locally Advanced Head and Neck Cancer
The median progression-free survival was not reached in either treatment group at a median follow-up of 15 months.
Palliative Care in Head and Neck Cancer: One Size Doesn’t Fit All
A study found no benefit to early palliative care interventions, suggesting a one-size-fits-all approach won’t work in head and neck cancer.
RB-RECIST Criteria May Improve Retinoblastoma Management: An Interview With Jesse L. Berry, MD
In an international, multicenter collaboration, experts modified the RECIST criteria for use as objective endpoints in clinical trials of retinoblastoma therapies.
COVID-19 Vaccination and Imaging Misinterpretation: An Interview With Lacey McIntosh, DO, MPH
Oncologists and patients should be aware of the potential manifestations of the COVID-19 vaccination on imaging and the consequences this might have on disease assessment, treatment monitoring, and decision-making.
Endoscopic Surgery Improved OS for Locally Recurrent Nasopharyngeal Cancer
A team of investigators conducted a randomized controlled trial to assess outcomes following salvage endoscopic surgery vs radiation therapy in patients with resectable, locally recurrent nasopharyngeal cancer.
KESTREL Trial Testing Durvalumab With or Without Tremelimumab in HNSCC Misses OS End Points
Investigators of the phase 3 KESTREL trial recruited 823 patients with previously untreated recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
Study Establishes Feasibility of Reduced-Dose IMRT Plus Cisplatin in Good-Risk HPV-Associated OPSCC
Investigators tested the efficacy of reduced-dose radiation plus cisplatin in patients with good-risk human papillomavirus–associated oropharyngeal squamous cell carcinoma (OPSCC).
American Cancer Society 2021 Statistics Report Shows Continuous Decline in Cancer Mortality Rate, Illuminates Disease-Specific Trends
The American Cancer Society’s annual report approximates the new cancer diagnoses and deaths expected in 2021 and identifies impactful patterns in oncology care.
Symptom Assessment Scores Associated With Unplanned Hospitalizations in Patients With Head and Neck Cancer
Population-based study demonstrated an association between patient-reported outcomes and ED visits/unplanned hospitalizations among patients with head and neck cancer.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...